AndreaRamirezG

Rheumatologist University of Chicago

[AndreaRamirezG @Andrearamgom]

@LaceyFeigl @ilee_md @moMDPhD @drmapaley @ACRheum Miss you all!

[MedEdPORTAL @MedEdPORTAL]

In this @WUSTLmed workshop from @JakeMurrayRheum @LisaZickuhr @Andrearamgom @AmberDeptola residents learn to perform knee & shoulder arthrocentesis through simulated scenarios & assessment tools with strong reliability & validity evidence. https://t.co/3Ki6Hs2Hwh #MEPFeature

[Mike Putman @EBRheum]

Nifty little read about dx and tx algorithms in monogenic autoinflammatory disease

I think we need to start generating more diagnostic algorithms and "approach to" articles

Working on a series for my fellows and have had a hard time finding material!

[KenWarringtonMD @MdWarrington]

Radiology #innovation @MayoClinic
#Photon counting CT with amazing resolution of medium sized vessels
Patient with acute intra abdominal bleed
#vasculitis mimic #FMD - not #PAN

Glad to avoid #glucocorticoids and cyclophosphamide!

[Mario Pompermayer MD, RhMSUS @pompermarioMD]

Do you like/love Musculoskeletal Ultrasound (#MSUS) in general, as well as in Rheumatology (#RhMSUS)? You must follow/watch this👇@Rheumatology #POCUS #MSKUS

[Iazsmin Bauer Ventura, MD @IazsminBV]

We fundraise because we care. We care about patients with #Myositis and want to fund research, novel treatments, a cure to these diseases. Fundraise with us @TheMyositisAssc! Chicago for Myositis. Please RT!
https://t.co/5uzLig42yw

[Vasculitis 2022 @Vasculitis2022]

Parallel Session V: Outcomes

Cardiovascular Burden in Patients With ANCA-Associated and Non-ANCA Associated Vasculitis

Dr. Ana B Arevalo

@ANABELENAREVAL2

#Vasculitis22

[Dr. Glaucomflecken @DGlaucomflecken]

Time for some new CDC guidelines

[AndreaRamirezG @Andrearamgom]

@WUSTL_Rheum I miss you all! I want a box haha

[Shematologist, MD @acweyand]

Medical specialties as #TedLasso characters. A #MedLasso thread.

Starting with @TedLasso whose eternal optimism and relentless cheer is so obviously pediatrics.

See also: Dani Rojas
1/

[AndreaRamirezG @Andrearamgom]

@Janetbirdope @RheumNow @jeffsparks PsA? Vinyl Chloride acroosteolysis?

[Olivia Cardenas-Trowers, MD @otrowers_md]

Can we get a thread going of tips n’ tricks for new attending physicians? Asking for me 😅

[AndreaRamirezG @Andrearamgom]

@rabihmgeha This is a wonderful schema! I would consider adding livedoid vasculopathy (skin limited) and malignant atrophic papulosis (systemic).

[Kevin Hegarty @kghegarty]

How the coronavirus infects cells, evades detection and multiplies. Very nice summary of what we are dealing with. #covid19

https://t.co/on7p3YgPpe

[Dr. Dinesh Khanna @sclerodermaUM]

our review in @ACR_Journals https://t.co/ZRFMIXV9kf SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: How to incorporate two Food and Drug Administration-approved therapies in clinical practice @UMIntMed #nintedanib and #tocilizumab in SSc-ILD

[Dr. John Cush @RheumNow]

Textbooks say fever is common in lupus ("36%–86%") BUT IT IS NOT! Lupus is cause of FUO in 5%; Fever is seen in a minority of SLE onsets; Fever occurs w/ SLE complications - vasculitis, pneumonitis/serositis/alveolar hem, CNS, & INFECTION!

https://t.co/KvZeo6Q1WY

[Adi @IDdocAdi]

When you finally finish training and become an “independent” attending https://t.co/InM76XUWiz

[Renaud Felten @DocFelten]

Immunogenicity of the Pfizer/BioNTech COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases compared to general population.
https://t.co/KHyiWmgn4z
Treatment with glucocorticoids, rituximab,
MMF, abatacept was associated with a
reduced immunogenicity

[Mike Putman @EBRheum]

May as well join the fun: TYPES OF [X] PAPERS - RHEUM-EDITION!

Special thanks to @BenMazer for this article https://t.co/puC4PMCfc5

And to this website: https://t.co/8B1AdtVBxz

And sorry if someone already did this! Had not seen yet for rheum but wouldn't be surprised ;)

[Alfred Kim @alhkim]

On behalf of the entire #COVaRiPAD team, we are thrilled to announce our preprint reporting humoral responses after BOTH doses of mRNA-based SARS-CoV-2 vax in 133 pts w/ chronic inflammatory diseases (CID) and 53 immunocompetent controls: https://t.co/s6a3J1bKGZ.
1/